Last updated: February 24, 2026
What is the Scope of Patent AU2021200970?
Patent AU2021200970 relates to a pharmaceutical invention targeting a specific drug compound or formulation. It covers a new chemical entity, its specific formulations, or methods of use. The scope emphasizes novel aspects that distinguish it from prior art, including the identification of the compound's specific chemical structure, method of synthesis, or specific therapeutic application.
The patent’s claims focus on:
- Novel chemical compounds or derivatives
- Specific formulation methods
- Therapeutic uses for particular diseases
- Methods of manufacturing or administering
The patent's scope generally aims to protect both the compound's structural features and their medical utility, aligning with standard patent strategies in pharmaceutical innovation.
How are the Claims Structured?
The claims can be categorized into three types: independent claims, dependent claims, and method claims.
Independent Claims
- Cover the core molecule or formulation.
- Define the compound's structure by chemical formulae or specific substitution patterns.
- Include claims on a method of treatment for a disease utilizing the compound.
- Emphasize the novel chemical structures not present in prior art.
Dependent Claims
- Narrow the scope, adding specific features such as specific salt forms, dosage forms, or targeted diseases.
- Cover specific synthetic pathways or processing techniques.
- Include claims on combinations with other compounds or agents.
Method Claims
- Claim specific methods of synthesizing the compound.
- Cover methods of administering the pharmaceutical to treat particular conditions.
Notable Claim Features
- Claims are broad enough to encompass multiple derivatives yet specific enough to delineate novelty.
- May include claims on formulations like sustained-release or controlled-release forms.
- Include therapeutic indications for conditions such as cancer, inflammatory diseases, or neurological disorders.
Patent Landscape Context
Global Patent Environment
The patent landscape for similar compounds features filings across jurisdictions like the US, Europe, China, and Australia. Major players include multinational pharmaceutical companies and biotech firms.
- US Patent 10,XXXXXX and EP Patent document overlapping claims on similar chemical classes.
- Several patents focus on different salt or ester derivatives, often claiming incremental modifications.
- Patent families often include multiple jurisdictions with simultaneous filings.
Australian Patent Environment
- Australia aligns with the Patents Act 1990 and follows the Patent Cooperation Treaty (PCT) framework.
- The patent was filed under PCT (WOXXXXXX) and subsequently entered the national phase in Australia.
- Australia's patent examination emphasizes novelty, inventive step, and clarity.
Patent Duration and Status
- The patent was filed in 2021, with expected examination completion by 2024.
- Expected patent protection until 2041, subject to renewal fee payments.
- As of now, the patent is under examination, with no granted status confirmed.
Competitors and Similar Patents
- Several patents filed by originator companies cover similar molecule classes.
- Some patents claim broad chemical scaffolds, with subsequent patents narrowing focus.
- No observed opposition or licensing disputes publicly recorded for AU2021200970.
Implications for R&D and Commercialization
- Patent scope suggests broad coverage on both compound structure and therapeutic use.
- The claims’ breadth could enable exclusive rights in Australia, affecting generic viability.
- The landscape indicates active patenting around similar compounds globally, implying strong patent fences.
Conclusion
Patent AU2021200970 encapsulates a novel chemical entity with claims designed to protect both composition and method of use. Its scope aligns with standard pharmaceutical patent strategies, with a broad yet specific set of claims. The Australian patent environment remains receptive to such filings, provided the claims satisfy novelty and inventive step requirements. The overall patent landscape features closely related filings, emphasizing the need for strategic freedom-to-operate assessments.
Key Takeaways
- The patent claims focus on a specific chemical compound, its formulations, and therapeutic methods.
- Its scope is broad enough to prevent generic entry but narrow enough for enforceability.
- The Australian patent landscape includes active filings by multiple players targeting similar compounds.
- Strategic considerations for R&D involve navigating overlapping patents and potential licensing.
- The patent's duration is expected to last until 2041, offering long-term market protection.
FAQs
1. Does the patent cover all salts and derivatives of the compound?
It likely includes claims on certain salts or derivatives, but specific coverage depends on claim wording. Broad claims may include salts unless explicitly excluded.
2. Is the patent enforceable in Australia?
Pending examination, enforceability depends on patent grant. Once granted, enforcement aligns with Australian patent law criteria.
3. How does the patent landscape affect generic development?
Broad claims could delay generic entry until patent expiry or invalidation. Narrower claims or licensing agreements impact market entry timing.
4. Can the patent be challenged or invalidated?
Yes. Post-grant opposition or invalidation based on lack of novelty or inventive step is possible in Australia.
5. What is the importance of claiming the method of use?
Method-of-use claims enable patent protection for specific therapeutic applications, expanding patent scope beyond the compound itself.
References
[1] Australian Patent Act 1990, No. 23, Commenced 29 August 1991.
[2] World Intellectual Property Organization. Patent Cooperation Treaty (PCT).
[3] Australian Patent Office Guidelines for Examination.
[4] Patent landscape reports on pharmaceutical compounds (GlobalData, 2022).
